Lv2
130 积分 2024-06-20 加入
Prevalence and Treatment of Diabetes in China, 2013-2018
2天前
已完结
Multimodal prediction of response to neoadjuvant nivolumab and chemotherapy for surgically resectable stage IIIA non–small cell lung cancer
18天前
已完结
US Food and Drug Administration Approval Summary: Nivolumab Plus Platinum-Doublet Chemotherapy for the Neoadjuvant Treatment of Patients With Resectable Non–Small-Cell Lung Cancer
1个月前
已完结
Prognostic impact of the number and total tumor burden of secondary cerebral lesions in patients with resected brain metastases of non–small cell lung cancers
1个月前
已完结
932MO Nivolumab (NIVO) plus platinum-doublet chemotherapy (chemo) versus chemo as neoadjuvant treatment for resectable non-small cell lung cancer (NSCLC): Health-related quality of life (HRQoL) outcomes from CheckMate 816
1个月前
已完结
Perioperative immune checkpoint blockades improve prognosis of resectable non-small cell lung cancer
1个月前
已关闭
NSCLC, early stage Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer
1个月前
已完结
Survival and Early Death Within Three Months from the Start of Immune Checkpoint Inhibitors in Patients With Different Types of Cancer
1个月前
已完结
Probabilistic sensitivity analysis in health economics
3个月前
已完结
Lung Adjuvant Cisplatin Evaluation: A Pooled Analysis by the LACE Collaborative Group
3个月前
已完结
皖公网安备34019202002308
